Global Coronary Stents Market expected to reach USD 14.2 Billion by 2020

Coronary Stents Market Analysis and Forecast 2013-2020 report estimates the global coronary stents market to reach nearly USD 14.2 Billion in 2020, at a CAGR of 8.8% from 2016 to 2020 - iHealthcareAnalyst, Inc.

Visit the Coronary Stents Market Analysis and Forecast 2013-2020 report http://www.ihealthcareanalyst.com/report/coronary-stents-market/
The global coronary stents market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

A coronary stent are tube-shaped devices placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI). Stents reduce chest pain and have been shown to improve survivability in the event of an acute myocardial infarction.

The global coronary stents market segmentation is based on product types (Bare Metal Stents, Drug Eluting Stents, Bio-absorbable Stents), and products in pipeline (CORACTO, EXCELLA II and EXCELLA BD, DESolve Nx and DESolve FIM, ZoMaxx I and ZoMaxx II, ABSORB STEMI, BioFreedom, TAXUS PERSEUS, BioNIR). The global coronary stents market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global coronary stents market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Product Type
1.1. Bare Metal Stents
1.2. Drug Eluting Stents
1.3. Bio-absorbable Stents

2. Product Pipeline
2.1. CORACTO
2.2. EXCELLA II and EXCELLA BD
2.3. DESolve Nx and DESolve FIM
2.4. ZoMaxx I and ZoMaxx II
2.5. ABSORB STEMI
2.6. BioFreedom
2.7. TAXUS PERSEUS
2.8. BioNIR

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Abbott Laboratories, Inc.
4.2. amg International GmbH
4.3. B. Braun Melsungen AG
4.4. Biotronik SE & Co. KG
4.5. Boston Scientific Corporation
4.6. C. R. Bard, Inc.
4.7. Cook Medical, Inc.
4.8. Johnson & Johnson
4.9. Medtronic, Inc.
4.10. MicroPort Scientific Corporation
4.11. STENTYS SA
4.12. Terumo Corporation

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.